Pharma Industry
Industry: Email Alert RSS FeedIntron-A/Aldara combination therapy for BCC
Journal of Drugs in Dermatology, Feb, 2008
Sponsored by: The University of Texas Health Science Center, Houston. The purpose of this study is to see if BCC excluding the scalp and face can be treated successfully with a combination therapy of Intron[R]-A and Aldara[R].
Condition Intervention Phase Basal Cell Carcinoma Biological: Imiquimod Phase IV Excluding Scalp and Interferon alpha and Face
Study ID Numbers: HSC-MS-06-0478, OSP-24412
Most RecentPharma Articles
- Lucky Number 12? Biogenerics Legislation Trudges Forward
- "Bribe" or No, Pfizer May Get Its Way in Philippines
- FDA Admits It Was Wrong to Ax Critic of Lilly's Effient
- UPDATED: Shire Accused of Depriving Family of Metazym Even Though They Raised...
- Suits Claim Bayer's Yaz Caused 50 Deaths; Novel Theory of Blood Clot Causation
- More »
ClinicalTrials.gov Identifier: NCT00581425
COPYRIGHT 2008 Journal of Drugs in Dermatology, Inc.
COPYRIGHT 2008 Gale, Cengage Learning
Brought to you by CBS MoneyWatch.com
- 10 Best Places to Retire
- Companies with the Best 401(k) Plans
- Most Important Document for Your Heirs? It's Not Your Will
- Video: Should You Expect to Retire Rich?
- Over 50? Here's How to Get (and Keep) a Great Job
Most Recent Health Articles
Most Recent Health Publications
Most Popular Health Articles
- Detox in 7 days: a detoux diet can help you shed up to 10 pounds and leave you feeling terrific. Our weeklong plan shows you how to lose the weight and keep it off - Cover story
- All about nightshades: explore the hidden hazards of your favorite food with macrobiotic nutritionist Lino Stanchich
- La anemia falciforme - causas y tratamiento
- The sour truth about apple cider vinegar - evaluation of therapeutic use
- Treat sinusitis naturally: breath easy and relieve sinus pressure with these remedies - Quick Fixes and Long-Term Solutions
Most Popular Health Publications
Content provided in partnership with
